• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性药物的纳米颗粒制剂:改善靶向性和生物分布特性的策略。

Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties.

作者信息

Datta Pallab, Ray Soumendranath

机构信息

Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology Shibpur, Howrah, India.

Division of Nuclear Medicine, Tata Medical Centre, Kolkata, India.

出版信息

J Labelled Comp Radiopharm. 2020 Mar 27. doi: 10.1002/jlcr.3839.

DOI:10.1002/jlcr.3839
PMID:32220029
Abstract

Application of nanotechnology principles in drug delivery has created opportunities for treatment of several diseases. Nanotechnology offers the advantage of overcoming the adverse biopharmaceutics or pharmacokinetic properties of drug molecules, to be determined by the transport properties of the particles themselves. Through the manipulation of size, shape, charge, and type of nanoparticle delivery system, variety of distribution profiles may be obtained. However, there still exists greater need to derive and standardize definitive structure property relationships for the distribution profiles of the delivery system. When applied to radiopharmaceuticals, the delivery systems assume greater significance. For the safety and efficacy of both diagnostics and therapeutic radiopharmaceuticals, selective localization in target tissue is even more important. At the same time, the synthesis and fabrication reactions of radiolabelled nanoparticles need to be completed in much shorter time. Moreover, the extensive understanding of the several interesting optical and magnetic properties of materials in nanoscale provides for achieving multiple objectives in nuclear medicine. This review discusses the various nanoparticle systems, which are applied for radionuclides and analyses the important bottlenecks that are required to be overcome for their more widespread clinical adaptation.

摘要

纳米技术原理在药物递送中的应用为多种疾病的治疗创造了机会。纳米技术具有克服药物分子不良生物药剂学或药代动力学性质的优势,这取决于颗粒本身的传输特性。通过操纵纳米颗粒递送系统的大小、形状、电荷和类型,可以获得多种分布概况。然而,对于递送系统的分布概况,仍然更需要推导并标准化明确的结构-性质关系。当应用于放射性药物时,递送系统具有更重要的意义。对于诊断和治疗性放射性药物的安全性和有效性而言,在靶组织中的选择性定位更为重要。同时,放射性标记纳米颗粒的合成和制备反应需要在更短的时间内完成。此外,对纳米级材料的几种有趣光学和磁性性质的广泛了解有助于在核医学中实现多个目标。本综述讨论了应用于放射性核素的各种纳米颗粒系统,并分析了为使其更广泛地应用于临床而需要克服的重要瓶颈。

相似文献

1
Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties.放射性药物的纳米颗粒制剂:改善靶向性和生物分布特性的策略。
J Labelled Comp Radiopharm. 2020 Mar 27. doi: 10.1002/jlcr.3839.
2
Nanosize drug delivery system.纳米尺寸药物递送系统。
Curr Pharm Biotechnol. 2013;14(15):1221. doi: 10.2174/138920101415140804121008.
3
Nanotechnological selection.纳米技术选择。
Nanotechnology. 2013 Jan 18;24(2):020201. doi: 10.1088/0957-4484/24/2/020201. Epub 2012 Dec 14.
4
Nano-radiopharmaceuticals as therapeutic agents.纳米放射性药物作为治疗剂。
Front Med (Lausanne). 2024 Mar 15;11:1355058. doi: 10.3389/fmed.2024.1355058. eCollection 2024.
5
Nanobiotechnology-based drug delivery in brain targeting.基于纳米生物技术的脑靶向给药
Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719.
6
Nanotechnology and radiopharmaceuticals: diagnostic and therapeutic approaches.纳米技术与放射性药物:诊断与治疗方法。
Curr Drug Deliv. 2010 Apr;7(2):168-74. doi: 10.2174/156720110791011837.
7
Radiopharmaceutical enhancement by drug delivery systems: A review.放射性药物给药系统的增强作用:综述。
J Control Release. 2018 Oct 10;287:177-193. doi: 10.1016/j.jconrel.2018.08.008. Epub 2018 Aug 4.
8
Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.多功能放射性标记纳米颗粒:癌症治疗用放射性药物的策略与新分类
J Drug Target. 2015 Apr;23(3):191-201. doi: 10.3109/1061186X.2014.988216. Epub 2014 Dec 23.
9
Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.具有不同 mPEG 含量的 PLGA 纳米粒的基于生理学的药代动力学建模。
Int J Nanomedicine. 2012;7:1345-56. doi: 10.2147/IJN.S23758. Epub 2012 Mar 7.
10
Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts.用于癌症诊断与治疗的放射性标记纳米材料:原理与概念
Cancer Nanotechnol. 2023;14(1):15. doi: 10.1186/s12645-023-00165-y. Epub 2023 Feb 27.

引用本文的文献

1
Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.推动小分子酪氨酸激酶抑制剂纳米制剂的生物制药和药代动力学特性。
Asian J Pharm Sci. 2024 Dec;19(6):100980. doi: 10.1016/j.ajps.2024.100980. Epub 2024 Oct 26.
2
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer.用PSMA/BN配体功能化的放射性标记氧化铁纳米颗粒用于前列腺癌的双靶点治疗。
Front Nucl Med. 2023 Sep 20;3:1184309. doi: 10.3389/fnume.2023.1184309. eCollection 2023.
3
Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer.
用于前列腺癌精准诊断与治疗的放射性核素诊疗策略的进展
EJNMMI Radiopharm Chem. 2024 Aug 24;9(1):62. doi: 10.1186/s41181-024-00295-7.
4
Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics.肺癌的分子成像:探索放射性标记诊断中的小分子、肽类及其他物质
Pharmaceutics. 2024 Mar 15;16(3):404. doi: 10.3390/pharmaceutics16030404.
5
Radiolabeled Human Serum Albumin Nanoparticles Co-Loaded with Methotrexate and Decorated with Trastuzumab for Breast Cancer Diagnosis.负载甲氨蝶呤并经曲妥珠单抗修饰的放射性标记人血清白蛋白纳米颗粒用于乳腺癌诊断
J Funct Biomater. 2023 Sep 18;14(9):477. doi: 10.3390/jfb14090477.
6
In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications.用于医疗应用的磁性氧化铁纳米粒子的体内生物分布和清除。
Int J Nanomedicine. 2023 Jul 26;18:4067-4100. doi: 10.2147/IJN.S415063. eCollection 2023.
7
Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties.使用锝-99m标记的脂质体药物时放射性药物的增强疗效:合成与药代动力学特性
Biomedicines. 2022 Nov 21;10(11):2994. doi: 10.3390/biomedicines10112994.
8
Nanomedicine approaches for treatment of hematologic and oncologic malignancies.用于治疗血液学和肿瘤学恶性肿瘤的纳米医学方法。
World J Clin Oncol. 2022 Jul 24;13(7):553-566. doi: 10.5306/wjco.v13.i7.553.
9
Nanomicelles of Radium Dichloride [Ra]RaCl Co-Loaded with Radioactive Gold [Au]Au Nanoparticles for Targeted Alpha-Beta Radionuclide Therapy of Osteosarcoma.负载放射性金[Au]纳米颗粒的二氯化镭[Ra]RaCl纳米胶束用于骨肉瘤的靶向α-β放射性核素治疗。
Polymers (Basel). 2022 Mar 30;14(7):1405. doi: 10.3390/polym14071405.
10
A review of advances in the last decade on targeted cancer therapy using Lu: focusing on Lu produced by the direct neutron activation route.过去十年间镥在靶向癌症治疗方面的进展综述:聚焦于通过直接中子活化途径产生的镥。
Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):443-475. eCollection 2021.